Ocular penetration of levofloxacin, ofloxacin and ciprofloxacin in eyes with functioning filtering blebs: Investigator masked, randomised clinical trial

British Journal of Ophthalmology

Volumn 92, Issue 3, 2008, Pages 345-347

  Cantor, L B ^a   WuDunn, D ^a   Yung, C W ^a   Valluri, S ^a   Catoira, Y P ^a   Hoop, J S ^a   Morgan, L S ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CIPROFLOXACIN; LEVOFLOXACIN; OFLOXACIN;

ADULT; AQUEOUS HUMOR; ARTICLE; CATARACT; CATARACT EXTRACTION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG PENETRATION; FILTERING BLEB; GLAUCOMA DRAINAGE IMPLANT; HUMAN; MASS SPECTROMETRY; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STATISTICAL SIGNIFICANCE;

ADMINISTRATION, ORAL; ANTI-BACTERIAL AGENTS; AQUEOUS HUMOR; CATARACT EXTRACTION; CIPROFLOXACIN; DRUG THERAPY, COMBINATION; EYE INFECTIONS, BACTERIAL; FILTERING SURGERY; HUMANS; OFLOXACIN; OPHTHALMIC SOLUTIONS; PROSPECTIVE STUDIES; SINGLE-BLIND METHOD; SURGICAL WOUND INFECTION;

EID: 40549116993     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.2007.121541     Document Type: Article

References (11)

1. Greenfield DS, Suner IJ, Miller MP, et al. Endophthalmitis after filtering surgery with mitomycin. Arch Ophthalmol 1996;114:943-9.
2. Waheed S, Ritterband DC, Greenfield DS, et al. New patterns of infecting organisms in late bleb-related endophthalmitis: a ten year review. Eye 1998;12:910-5.
3. Donnenfeld ED, Perry HD, Snyder RW, et al. Intracorneal, aqueous humor, and vitreous humor penetration of topical and oral ofloxacin. Arch Ophthalmol 1997;115:173-6.
4. Cantor LB, Donnenfeld E, Katz J, et al. Penetration of ofloxacin and ciprofloxacin into the aqueous humor of eyes with functioning filtering blebs. Arch Ophthalmol 2001;119:1254-7.
5. Liang H, Kays MB, Sowinski KM. Separation of levofloxacin, ciprofloxacin, gatifloxacin, moxifloxacin, trovafloxacin, and cinoxacin by high-performance liquid chromatography: application to levofloxacin determination in human plasma. J Chromatogr B Anal Technol Biomed Life Sci 2002;772:53-63.
6. Healy DP, Holland EJ, Nordlund ML, et al. Concentrations of levofloxacin, ofloxacin and ciprofloxacin in human corneal stromal tissue and aqueous humor after topical administration. Cornea 2003;23:255-63.
7. Cantor LB, Mantravadi AV, WuDunn D, et al. Morphologic classification of filtering blebs following glaucoma filtration surgery: The Indiana Bleb Appearance Grading Scale (IBAGS). J Glaucom 2003;12:266-71.
8. Koch HR, Kulus SC, Roessler M, et al. Corneal penetration of fluroquinolones: aqueous concentration after topical application of levofloxacin 0.5% and ofloxacin 0.3% eyedrops. J Cataract Refract Surg 2005;31:1377-85.
9. Colin J, Simonpoli S, Geldsetzer K, et al. Corneal penetration of levofloxacin into the human aqueous humour: a comparison with ciprofloxacin. Acta Ophthalmol Scand 2003;81:611-3.
10. Hwang DG, Schanzlin DJ, Rotberg MH, et al. A phase III, placebo controlled clinical trial of 0.5% levofloxacin ophthalmic solution for the treatment of bacterial conjunctivitis. Br J Ophthalmol 2003;87:1004-9.
11. Kowalski RP, Dhaliwal DK, Karenchak LM, et al. Gatifloxacin and moxifloxacin: an in vitro susceptibility comparison to levofloxacin, ciprofloxacin, and ofloxacin using bacterial keratitis isolates. Am J Ophthalmol 2003;136:500-5.